These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25147317)

  • 1. Prevalence and nature of antipsychotic polypharmacy among inpatients with schizophrenia spectrum disorders at an Australian mental health service.
    John AP; Gee T; Alexander S; Ramankutty P; Dragovic M
    Australas Psychiatry; 2014 Dec; 22(6):546-50. PubMed ID: 25147317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Social and clinical descriptors of antipsychotic prescription.
    Piccinni C; Piazza A; Poluzzi E; Tarricone I; Koci A; Berardi D; Fioritti A; de Ponti F
    Int J Psychiatry Med; 2015; 49(1):45-62. PubMed ID: 25838320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotic polypharmacy in inpatients with schizophrenia in Asia (2001-2009).
    Xiang YT; Wang CY; Si TM; Lee EH; He YL; Ungvari GS; Chiu HF; Yang SY; Chong MY; Tan CH; Kua EH; Fujii S; Sim K; Yong KH; Trivedi JK; Chung EK; Udomratn P; Chee KY; Sartorius N; Shinfuku N
    Pharmacopsychiatry; 2012 Jan; 45(1):7-12. PubMed ID: 21989602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and correlates of antipsychotic polypharmacy in Hong Kong.
    Lung SLM; Lee HME; Chen YHE; Chan KWS; Chang WC; Hui LMC
    Asian J Psychiatr; 2018 Mar; 33():113-120. PubMed ID: 29574303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic polypharmacy in patients with schizophrenia in a brief hospitalization unit.
    Lerma-Carrillo I; de Pablo Brühlmann S; del Pozo ML; Pascual-Pinazo F; Molina JD; Baca-García E
    Clin Neuropharmacol; 2008; 31(6):319-32. PubMed ID: 19050409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and correlates of antipsychotic polypharmacy among patients with schizophrenia in Denmark: A nation-wide pharmacoepidemiological study.
    Sneider B; Pristed SG; Correll CU; Nielsen J
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1669-76. PubMed ID: 26256007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring regional variation in antipsychotic coprescribing practice: a Danish questionnaire survey.
    Baandrup L; Allerup P; Nordentoft M; Lublin H; Glenthoj BY
    J Clin Psychiatry; 2010 Nov; 71(11):1457-64. PubMed ID: 21034689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risks and benefits of switching patients with schizophrenia or schizoaffective disorder from two to one antipsychotic medication: a randomized controlled trial.
    Constantine RJ; Andel R; McPherson M; Tandon R
    Schizophr Res; 2015 Aug; 166(1-3):194-200. PubMed ID: 26141142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Queensland Mental Health Clinical Collaborative and the management of schizophrenia.
    Plever S; Emmerson B; Chapple B; Kennedy C; Groves A
    Australas Psychiatry; 2010 Apr; 18(2):106-14. PubMed ID: 20039842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient characteristics and process factors associated with antipsychotic polypharmacy in a nationwide sample of psychiatric inpatients in Italy.
    Santone G; Bellantuono C; Rucci P; Picardi A; Preti A; de Girolamo G
    Pharmacoepidemiol Drug Saf; 2011 May; 20(5):441-9. PubMed ID: 21523847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
    Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
    Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic polypharmacy in schizophrenia patients in China and its association with treatment satisfaction and quality of life: findings of the third national survey on use of psychotropic medications in China.
    Li Q; Xiang YT; Su YA; Shu L; Yu X; Chiu HF; Correll CU; Ungvari GS; Lai KY; Ma C; Wang GH; Bai PS; Li T; Sun LZ; Shi JG; Chen XS; Mei QY; Li KQ; Si TM
    Aust N Z J Psychiatry; 2015 Feb; 49(2):129-36. PubMed ID: 24923760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Explicit versus implicit review to explore combination antipsychotic prescribing.
    Wheeler A
    J Eval Clin Pract; 2009 Aug; 15(4):685-91. PubMed ID: 19674220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.
    Loosbrock DL; Zhao Z; Johnstone BM; Morris LS
    J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risperidone long-acting therapy prescribing patterns and their impact on early discontinuation of treatment in a large Medicaid population.
    Boaz TL; Constantine RJ; Robst J; Becker MA; Howe AM
    J Clin Psychiatry; 2011 Aug; 72(8):1079-85. PubMed ID: 21034690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophrenia.
    Hazra M; Uchida H; Sproule B; Remington G; Suzuki T; Mamo DC
    Psychiatry Clin Neurosci; 2011 Dec; 65(7):676-8. PubMed ID: 22176287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
    Wheeler AJ
    Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotic prescribing pathways, polypharmacy, and clozapine use in treatment of schizophrenia.
    Gören JL; Meterko M; Williams S; Young GJ; Baker E; Chou CH; Kilbourne AM; Bauer MS
    Psychiatr Serv; 2013 Jun; 64(6):527-33. PubMed ID: 23450334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription profiles for pharmacological treatment of Japanese inpatients with schizophrenia: comparison between 2007 and 2009.
    Yoshio T; Inada T; Uno J; Miwa T; Kitagawa K; Miyahara Y; Umeda K; Kato T; Inagaki A; Nabeshima T
    Hum Psychopharmacol; 2012 Jan; 27(1):70-5. PubMed ID: 22249957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsychotic polypharmacy and high-dose prescription in schizophrenia: a 5-year comparison.
    Roh D; Chang JG; Kim CH; Cho HS; An SK; Jung YC
    Aust N Z J Psychiatry; 2014 Jan; 48(1):52-60. PubMed ID: 23671214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.